WAVE LIFE SCIENCES LTD. Shares Issued
WAVE LIFE SCIENCES LTD. (WVE) had Shares Issued of 193.28 million shares as of 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Balance Sheet › Equity › Stockholders' Equity, Number of Shares, Par Value and Other Disclosure › Common Stock, Number of Shares, Par Value and Other Disclosure
us-gaap:CommonStockSharesIssued · last filed 2026-07-30
- 2026-06-30: Common Stock, Shares, Issued 193.28M shares.
- 2026-03-31: Common Stock, Shares, Issued 192.34M shares.
- 2025-12-31: Common Stock, Shares, Issued 187.66M shares.
- 2025-09-30: Common Stock, Shares, Issued 160.29M shares.
| Period end | Common Stock, Shares, Issued |
|---|---|
| 2026-06-30 | 193.28M shares 10-Q · filed 2026-07-30 |
| 2026-03-31 | 192.34M shares 10-Q · filed 2026-04-28 |
| 2025-12-31 | 187.66M shares 10-Q · filed 2026-07-30 |
| 2025-09-30 | 160.29M shares 10-Q · filed 2025-11-10 |
| 2025-06-30 | 155.67M shares 10-Q · filed 2025-07-30 |
| 2025-03-31 | 154.09M shares 10-Q · filed 2025-05-08 |
| 2024-12-31 | 153.04M shares 10-K · filed 2026-02-26 |
| 2024-09-30 | 148.39M shares 10-Q · filed 2024-11-12 |
| 2024-06-30 | 122.48M shares 10-Q · filed 2024-08-08 |
| 2024-03-31 | 122.32M shares 10-Q · filed 2024-05-10 |
| 2023-12-31 | 119.16M shares 10-K · filed 2025-03-04 |
| 2023-09-30 | 99.01M shares 10-Q · filed 2023-11-09 |
| 2023-06-30 | 98.57M shares 10-Q · filed 2023-08-03 |
| 2023-03-31 | 98.10M shares 10-Q · filed 2023-05-03 |
| 2022-12-31 | 86.92M shares 10-K · filed 2024-03-06 |
| 2022-09-30 | 86.84M shares 10-Q · filed 2022-11-10 |
| 2022-06-30 | 86.72M shares 10-Q · filed 2022-08-11 |
| 2022-03-31 | 60.86M shares 10-Q · filed 2022-05-12 |
| 2021-12-31 | 59.84M shares 10-K · filed 2023-03-23 |
| 2021-09-30 | 52.00M shares 10-Q · filed 2021-11-10 |
| 2021-06-30 | 50.58M shares 10-Q · filed 2021-08-05 |
| 2021-03-31 | 49.85M shares 10-Q · filed 2021-05-13 |
| 2020-12-31 | 48.78M shares 10-K · filed 2022-03-03 |
| 2020-09-30 | 48.77M shares 10-Q · filed 2020-11-09 |
| 2020-06-30 | 35.73M shares 10-Q · filed 2020-08-10 |
| 2020-03-31 | 34.60M shares 10-Q · filed 2020-05-11 |
| 2019-12-31 | 34.34M shares 10-K · filed 2021-03-04 |
| 2019-09-30 | 34.28M shares 10-Q · filed 2019-11-05 |
| 2019-06-30 | 34.27M shares 10-Q · filed 2019-08-06 |
| 2019-03-31 | 34.26M shares 10-Q · filed 2019-05-10 |
| 2018-12-31 | 29.47M shares 10-K · filed 2020-03-02 |
| 2018-09-30 | 29.43M shares 10-Q · filed 2018-11-09 |
| 2018-06-30 | 29.29M shares 10-Q · filed 2018-08-09 |
| 2018-03-31 | 27.99M shares 10-Q · filed 2018-05-09 |
| 2017-12-31 | 27.83M shares 10-K · filed 2019-03-01 |
| 2017-09-30 | 27.77M shares 10-Q · filed 2017-11-09 |
| 2017-06-30 | 27.73M shares 10-Q · filed 2017-08-09 |
| 2017-03-31 | 23.55M shares 10-Q · filed 2017-05-10 |
| 2016-12-31 | 23.50M shares 10-K · filed 2018-03-12 |
| 2016-09-30 | 23.47M shares 10-Q · filed 2016-11-09 |
| 2016-06-30 | 23.43M shares 10-Q · filed 2016-08-15 |
| 2016-03-31 | 21.55M shares 10-Q · filed 2016-05-16 |
| 2015-12-31 | 21.55M shares 10-K · filed 2017-03-16 |
| 2015-09-30 | 9.22M shares 10-Q · filed 2015-12-17 |
| 2014-12-31 | 4.26M shares 10-K · filed 2016-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |